Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/ refractory indolent lymphoma

Chan Yoon Cheah, Loretta J. Nastoupil, Sattva S. Neelapu, Sheryl G. Forbes, Yasuhiro Oki, Nathan H. Fowler

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{6000ccee7efe4a6b8bedbed6d18075fb,

title = "Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/ refractory indolent lymphoma",

author = "Cheah, {Chan Yoon} and Nastoupil, {Loretta J.} and Neelapu, {Sattva S.} and Forbes, {Sheryl G.} and Yasuhiro Oki and Fowler, {Nathan H.}",

year = "2015",

doi = "10.1182/blood-2015-03-633156",

language = "English",

volume = "125",

pages = "3357--3359",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "21",

}

TY - JOUR

T1 - Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/ refractory indolent lymphoma

AU - Cheah, Chan Yoon

AU - Nastoupil, Loretta J.

AU - Neelapu, Sattva S.

AU - Forbes, Sheryl G.

AU - Oki, Yasuhiro

AU - Fowler, Nathan H.

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84944960444&partnerID=8YFLogxK

U2 - 10.1182/blood-2015-03-633156

DO - 10.1182/blood-2015-03-633156

M3 - Letter

C2 - 25999447

AN - SCOPUS:84944960444

VL - 125

SP - 3357

EP - 3359

JO - Blood

JF - Blood

SN - 0006-4971

IS - 21

ER -